Skip to search formSkip to main contentSkip to account menu

technetium Tc 99m arcitumomab

Known as: technetium (99mTc) arcitumomab, Tc-99m Arcitumomab, arcitumomab, technetium-99m labeled 
A murine IgG monoclonal Fab' fragment antibody directed against carcinoembryonic antigen (CEA), a protein that is overexpressed by many tumor cell… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
PURPOSE To prospectively depict carcinoembryonic antigen (CEA)-expressing tumors in mice with a high-affinity probe consisting of… 
Highly Cited
1997
Highly Cited
1997
OBJECTIVE The objective was to determine the role of arcitumomab (CEA-Scan; Immunomedics, Morris Plains, NJ), an… 
1996
1996
This pilot project was undertaken to evaluate the toxicity of and tumor response to combined 131I anti–carcinoembryonic antigen… 
1995
1995
The aim of this study was to investigate targeting of the liver metastases by directly 99mTc-labeled complete (IgG) and… 
1995
1995
PURPOSE To prospectively compare the accuracy of imaging with technetium-99m-labeled Fab' fragment of the anti-carcinoembryonic… 
1994
1994
Background. Radioimmunodetection of cancer using monoclonal antibody fragments offers certain potential advantages over that with… 
1994
1994
PURPOSE We tested whether nuclear imaging with technetium 99m-labeled murine monoclonal antibody (MoAb) against carcinoembryonic…